Literature DB >> 12850853

A 27-year review of obstetric hysterectomy.

Rishi Roopnarinesingh1, Louise Fay, P McKenna.   

Abstract

A retrospective case-review of 52 mothers who had a peripartum hysterectomy over the past 27 years was conducted at the Rotunda hospital, Dublin, Ireland. The chief indications were uncontrollable haemorrhage due to rupture of the uterus, placenta praevia and uterine atony. Obstetric hysterectomy is a formidable operation, usually performed as a life-saving measure and requires expert surgical dexterity in order to minimise the significant morbidity. The benefits of the subtotal operation appear to be superior to those of total hysterectomy. Counselling patients having a caesarean section regarding the possibility of hysterectomy is advisable in those who have had previous uterine surgery, multiple caesarean sections or placenta praevia.

Entities:  

Mesh:

Year:  2003        PMID: 12850853     DOI: 10.1080/0144361031000098352

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  4 in total

1.  Emergency Obstetric Hysterectomy: A Retrospective Study from a Teaching Hospital in North India over Eight Years.

Authors:  Jaya Chawla; D Arora; Mohini Paul; Sangita N Ajmani
Journal:  Oman Med J       Date:  2015-05

2.  Emergency peripartum hysterectomy: a 13-year review at a tertiary center in kuwait.

Authors:  Ramadevi V Wani; Nasra M S Abu-Hudra; Sami Ibrahim Al-Tahir
Journal:  J Obstet Gynaecol India       Date:  2014-05-17

3.  Emergency hysterectomy in a tertiary care hospital: indications, surgical outcomes and challenges: a 2-year retrospective descriptive cross-sectional study.

Authors:  John Jude Kweku Annan; Thomas Opkoti Konney; Wilfred Sam-Awortwi; Kwasi Ampem Darkwa
Journal:  Pan Afr Med J       Date:  2020-10-01

Review 4.  Uterine Factor Infertility, a Systematic Review.

Authors:  Camille Sallée; François Margueritte; Pierre Marquet; Pascal Piver; Yves Aubard; Vincent Lavoué; Ludivine Dion; Tristan Gauthier
Journal:  J Clin Med       Date:  2022-08-21       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.